TY - JOUR
T1 - Considering patient values and treatment preferences enhances patient involvement in rectal cancer treatment decision making
AU - Kunneman, Marleen
AU - Marijnen, Corrie A. M.
AU - Baas-Thijssen, Monique C. M.
AU - van der Linden, Yvette M.
AU - Rozema, Tom
AU - Muller, Karin
AU - Geijsen, Elisabeth D.
AU - Stiggelbout, Anne M.
AU - Pieterse, Arwen H.
PY - 2015
Y1 - 2015
N2 - Background: The shared decision making (SDM) model states that patients' values and preferences should be clarified to choose a strategy that best fits the patient. This study aimed to assess whether values and preferences of rectal cancer patients are voiced and considered in deciding about preoperative radiotherapy (PRT), and whether this makes patients feel more involved in treatment decision making. Methods: Pre-treatment consultations of radiation oncologists and patients eligible for PRT were audio taped (N= 90). Tapes were transcribed and coded to identify patients' values and treatment preferences. Patients filled in a post-consultation questionnaire on their perceived involvement in decision making (N= 60). Results: Patients' values were voiced for 62/611 of benefits harms addressed (10%), in 38/90 consultations (42%; maximum 4 values per consultation), and most often related to major long-term treatment outcomes. Patients' treatment preferences were discussed in 20/90 consultations (22%). In 16/90 consultations (18%), the oncologists explicitly indicated to consider patients' values or preferences. Patients perceived a significantly more active role in decision making if their values or preferences had been voiced or considered. Conclusions: Patients' values and treatment preferences are voiced or considered in a minority of consultations. If they are, this increases patients' perceived involvement in the decision making process. (C) 2015 Elsevier Ireland Ltd. All rights reserved
AB - Background: The shared decision making (SDM) model states that patients' values and preferences should be clarified to choose a strategy that best fits the patient. This study aimed to assess whether values and preferences of rectal cancer patients are voiced and considered in deciding about preoperative radiotherapy (PRT), and whether this makes patients feel more involved in treatment decision making. Methods: Pre-treatment consultations of radiation oncologists and patients eligible for PRT were audio taped (N= 90). Tapes were transcribed and coded to identify patients' values and treatment preferences. Patients filled in a post-consultation questionnaire on their perceived involvement in decision making (N= 60). Results: Patients' values were voiced for 62/611 of benefits harms addressed (10%), in 38/90 consultations (42%; maximum 4 values per consultation), and most often related to major long-term treatment outcomes. Patients' treatment preferences were discussed in 20/90 consultations (22%). In 16/90 consultations (18%), the oncologists explicitly indicated to consider patients' values or preferences. Patients perceived a significantly more active role in decision making if their values or preferences had been voiced or considered. Conclusions: Patients' values and treatment preferences are voiced or considered in a minority of consultations. If they are, this increases patients' perceived involvement in the decision making process. (C) 2015 Elsevier Ireland Ltd. All rights reserved
U2 - https://doi.org/10.1016/j.radonc.2015.09.005
DO - https://doi.org/10.1016/j.radonc.2015.09.005
M3 - Article
C2 - 26372343
SN - 0167-8140
VL - 117
SP - 338
EP - 342
JO - Radiotherapy and oncology
JF - Radiotherapy and oncology
IS - 2
ER -